Routine

Pneumoconioses & occupational lung disease (silicosis, asbestosis, coal workers' pneumoconiosis)

pneumoconioses-occupational · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic fibrotic lung diseases from inhaled inorganic dusts: silicosis (quartz - mining, stone/engineered-stone cutting, sandblasting), asbestosis (asbestos), and coal workers' pneumoconiosis. There is no specific cure - management centres on exposure cessation, complication screening (TB, progressive massive fibrosis, lung cancer, mesothelioma), supportive care, and occupational/compensation processes. Highly relevant in India given silica and stone-industry exposure.

Red flags

  • New or worsening symptoms (consider superimposed TB, lung cancer, or mesothelioma)
  • Haemoptysis / weight loss
  • Progressive massive fibrosis (large upper-zone conglomerate masses)
  • Rapid progression (accelerated/acute silicosis from heavy engineered-stone exposure)
  • Pleural effusion in asbestos-exposed (exclude mesothelioma)
  • Right heart failure

Assessment

Differential diagnosis

  • Idiopathic pulmonary fibrosis / other ILD
  • Sarcoidosis
  • Tuberculosis (and silicotuberculosis)
  • Hypersensitivity pneumonitis
  • Lung cancer / mesothelioma
  • Chronic beryllium disease
  • COPD/emphysema from the same exposures

Investigations

  • Detailed OCCUPATIONAL and exposure history (job, dust type, duration, latency) - the diagnostic cornerstone
  • CXR (ILO classification: upper-zone nodular opacities in silicosis/CWP; lower-zone reticulation + pleural plaques in asbestosis)
  • HRCT thorax - better characterisation; identifies progressive massive fibrosis, plaques, early fibrosis
  • Spirometry + DLCO (restrictive +/- obstructive; reduced gas transfer)
  • ACTIVELY screen for TB - sputum AFB/culture + molecular test (silica greatly increases TB risk)
  • Exclude/monitor malignancy: lung cancer (silica, asbestos) and mesothelioma (asbestos) - low threshold for CT in new symptoms
  • Consider beryllium lymphocyte proliferation test if beryllium exposure
  • Assess for cor pulmonale (echo) in advanced disease

Management

  • Take a thorough occupational history and establish the dust/latency relationship
  • REMOVE from further exposure - the single most important intervention to prevent progression
  • Confirm pattern on CXR/HRCT and classify; exclude mimics (TB, sarcoid, IPF, malignancy)
  • Screen for and treat tuberculosis - silicosis markedly raises TB risk (silicotuberculosis); have a low threshold and consider LTBI treatment
  • Surveillance for complications: progressive massive fibrosis, lung cancer, mesothelioma (asbestos), cor pulmonale
  • Supportive care: smoking cessation (multiplicative cancer risk with asbestos), vaccination (influenza/pneumococcal), pulmonary rehabilitation, oxygen if hypoxaemic
  • Treat airflow limitation symptomatically (bronchodilators) and right heart failure as needed
  • Advise on occupational compensation, workplace dust control, and notify per local occupational-disease regulations; refer advanced disease for transplant assessment
  • Public-health angle: engineered/artificial stone (accelerated silicosis) is an emerging hazard needing workplace controls

Drugs & doses

No disease-specific drug therapy reverses the fibrosis - management is supportive and preventive
Anti-tuberculous therapy (2HRZE/4HR) if active TB; treat latent TB infection in silica-exposed per local policy [verify regimen]
Inhaled bronchodilators (LABA/LAMA) for coexisting airflow obstruction [verify product]
Supplemental oxygen (LTOT) if chronic hypoxaemia
Diuretics for cor pulmonale as indicated [verify dose]
Influenza/pneumococcal/COVID vaccination

Disposition

Outpatient respiratory/occupational-medicine management with complication surveillance. Notify occupational disease and support compensation claims. Admit for complications (TB, respiratory failure, suspected malignancy). Transplant referral in end-stage disease.

Complications & pitfalls

  • Progressive massive fibrosis and respiratory failure
  • Tuberculosis (silicotuberculosis) - markedly increased risk
  • Lung cancer (silica and asbestos; synergistic with smoking) and mesothelioma (asbestos)
  • Cor pulmonale
  • Pneumothorax
  • Autoimmune associations (silica: scleroderma, RA/Caplan syndrome, vasculitis)

Exam pearls

  • There is no cure - stopping exposure is the key intervention; prevention via workplace dust control is paramount (occupational health).
  • Silica dramatically increases TB risk - screen and maintain a low threshold for silicotuberculosis, and consider latent TB treatment.
  • Asbestos + smoking multiply lung-cancer risk - aggressive smoking cessation is essential; asbestos also causes mesothelioma (pleural plaques are a marker of exposure, not themselves malignant).
  • Engineered/artificial stone benchtop cutting causes accelerated silicosis in young workers - an emerging epidemic requiring exposure control (highly relevant in India).
  • A careful occupational history, not a lab test, usually makes the diagnosis.
  • Caplan syndrome = pneumoconiosis with rheumatoid nodules.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.